SOPHARMA AD - Sales revenues for the first nine months of 2017

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 101 / 2017

Date of issue: 2017-10-04

Short name of the issuer

SOPHARMA AD

Subject

Sales revenues for the first nine months of 2017

Official market - legal basis

art. 17. 1 MAR.

Unofficial market - legal basis

Contents of the report:

Sopharma AD notifies that for September 2017 the Company recorded an increase of sales revenues of 8% compared to the same month of 2016, including 1% decrease of domestic sales and 11% increase of export sales. For the first nine months of this year, revenues from sales increased by 16% compared to the same period of 2016, including 2% increase of domestic sales and a 25% increase of export sales. After the merger of Medica AD, from the beginning of the year the Company recorded an increase of sales revenues of 25%, including 29% increase of export sales and 19% increase of domestic sales.

Annexes

File Description

3JR Sales revenues 30 September 2017.doc Sales revenues for the first nine months of 2017

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2017-10-04 Ognian Donev Executive director